{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T19:21:14Z","timestamp":1790968874398,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1097\/jcp.0b013e31822c0adf","type":"journal-article","created":{"date-parts":[[2011,10,4]],"date-time":"2011-10-04T15:58:34Z","timestamp":1317743914000},"page":"582-586","source":"Crossref","is-referenced-by-count":34,"title":["Treatment of Major Depressive Disorder and Dysthymic Disorder With Antidepressants in Patients With Comorbid Opiate Use Disorders Enrolled in Methadone Maintenance Therapy"],"prefix":"10.1097","volume":"31","author":[{"given":"Paola","family":"Pedrelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Iovieno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tedeschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate H.","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George I.","family":"Papakostas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210128","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1471-244X-9-31","article-title":"Epidemiologic heterogeneity of common mood and anxiety disorders over the life course in the general population: a systematic review.","volume":"9","author":"Nandi","year":"2009","journal-title":"BMC Psychiatry"},{"issue":"3","key":"R2-7-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000069738","article-title":"The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach.","volume":"72","author":"Fava","year":"2003","journal-title":"Psychother Psychosom"},{"issue":"3","key":"R3-7-20210128","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0010-440X(86)90041-6","article-title":"A 2.5-year follow-up of short-term interpersonal psychotherapy in methadone-maintained opiate addicts.","volume":"27","author":"Rounsaville","year":"1986","journal-title":"Compr Psychiatry"},{"issue":"2","key":"R4-7-20210128","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpsyc.1982.04290020021004","article-title":"Diagnosis and symptoms of depression in opiate addicts. Course and relationship to treatment outcome.","volume":"39","author":"Rounsaville","year":"1982","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"R5-7-20210128","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00005053-199104000-00007","article-title":"Early treatment time course of depressive symptoms in opiate addicts.","volume":"179","author":"Strain","year":"1991","journal-title":"J Nerv Ment Dis"},{"issue":"3-4","key":"R6-7-20210128","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3109\/00952999009001594","article-title":"Evidence for altered desipramine disposition in methadone-maintained patients treated for cocaine abuse.","volume":"16","author":"Kosten","year":"1990","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"1","key":"R7-7-20210128","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archpsyc.1997.01830130077015","article-title":"Psychiatric and substance use comorbidity among treatment-seeking opioid abusers.","volume":"54","author":"Brooner","year":"1997","journal-title":"Arch Gen Psychiatry"},{"issue":"26","key":"R8-7-20210128","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1056\/NEJM200012283432607","article-title":"Managing depression in medical outpatients.","volume":"343","author":"Whooley","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"R9-7-20210128","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1176\/appi.ajp.2008.08071027","article-title":"Can phase III trial results of antidepressant medications be generalized to clinical practice? A STARD report.","volume":"166","author":"Wisniewski","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R10-7-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/JCP.0b013e318058263f","article-title":"Relevance of exclusion criteria in antidepressant clinical trials: a replication study.","volume":"27","author":"Zetin","year":"2007","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"R11-7-20210128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1176\/appi.ajp.159.2.191","article-title":"A reevaluation of the exclusion criteria used in antidepressant efficacy trials.","volume":"159","author":"Posternak","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"3","key":"R12-7-20210128","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1176\/appi.ajp.159.3.469","article-title":"Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?","volume":"159","author":"Zimmerman","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"2","key":"R13-7-20210128","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.nmd.0000110279.23893.82","article-title":"Exclusion criteria used in antidepressant efficacy trials: consistency across studies and representativeness of samples included.","volume":"192","author":"Zimmerman","year":"2004","journal-title":"J Nerv Ment Dis"},{"issue":"15","key":"R14-7-20210128","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1001\/jama.291.15.1887","article-title":"Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.","volume":"291","author":"Nunes","year":"2004","journal-title":"JAMA"},{"issue":"6","key":"R15-7-20210128","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archpsyc.1978.01770300115013","article-title":"Research diagnostic criteria: rationale and reliability.","volume":"35","author":"Spitzer","year":"1978","journal-title":"Arch Gen Psychiatry"},{"issue":"1","key":"R16-7-20210128","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/archpsyc.1972.01750190059011","article-title":"Diagnostic criteria for use in psychiatric research.","volume":"26","author":"Feighner","year":"1972","journal-title":"Arch Gen Psychiatry"},{"key":"R17-7-20210128","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-7-20210128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change.","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"issue":"14","key":"R20-7-20210128","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing.","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"issue":"6","key":"R21-7-20210128","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/archpsyc.1983.04390010059007","article-title":"Imipramine as treatment for depression in addicts.","volume":"40","author":"Kleber","year":"1983","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"R22-7-20210128","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.55.2.153","article-title":"Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial.","volume":"55","author":"Nunes","year":"1998","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"R23-7-20210128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.drugalcdep.2003.11.015","article-title":"The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial.","volume":"74","author":"Carpenter","year":"2004","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"R24-7-20210128","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0376-8716(98)00032-5","article-title":"Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts.","volume":"50","author":"Petrakis","year":"1998","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"R25-7-20210128","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.drugalcdep.2003.11.014","article-title":"Prevalence of psychiatric and substance use disorders in opioid abusers in a community syringe exchange program.","volume":"74","author":"Kidorf","year":"2004","journal-title":"Drug Alcohol Depend"},{"key":"R26-7-20210128","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jad.2006.09.017","article-title":"Depression in methadone maintenance treatment patients: rate and risk factors.","volume":"99","author":"Peles","year":"2007","journal-title":"J Affect Disord"},{"issue":"6","key":"R27-7-20210128","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/JGP.0b013e31816ff35a","article-title":"The prevalence of mental and physical health disorders among older methadone patients.","volume":"16","author":"Rosen","year":"2008","journal-title":"Am J Geriatr Psychiatry"},{"issue":"3","key":"R28-7-20210128","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.drugalcdep.2004.12.001","article-title":"Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): prevalence, correlates and treatment seeking.","volume":"78","author":"Teesson","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"R29-7-20210128","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0740-5472(99)00084-7","article-title":"Depression among needle exchange program and methadone maintenance clients.","volume":"18","author":"Brienza","year":"2000","journal-title":"J Subst Abuse Treat"},{"key":"R30-7-20210128","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/10550490903205652","article-title":"Psychiatric comorbidity reduces quality of life in chronic methadone maintained patients.","volume":"18","author":"Carpentier","year":"2009","journal-title":"Am J Addict"},{"issue":"8","key":"R31-7-20210128","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1001\/archpsyc.1986.01800080019003","article-title":"A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts.","volume":"43","author":"Kosten","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"8","key":"R32-7-20210128","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/archpsyc.1986.01800080025004","article-title":"Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study.","volume":"43","author":"Rounsaville","year":"1986","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"R33-7-20210128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00005053-198310000-00002","article-title":"Increased effectiveness of substance abuse treatment. A prospective study of patient-treatment \"matching\".","volume":"171","author":"McLellan","year":"1983","journal-title":"J Nerv Ment Dis"},{"issue":"10","key":"R34-7-20210128","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.biopsych.2004.06.037","article-title":"Treatment of depression in patients with opiate dependence.","volume":"56","author":"Nunes","year":"2004","journal-title":"Biol Psychiatry"},{"issue":"1","key":"R35-7-20210128","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2008.08.009","article-title":"Does the probability of receiving placebo influence clinical trial outcome? A meta-regression of double-blind, randomized clinical trials in MDD.","volume":"19","author":"Papakostas","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"R36-7-20210128","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/02791072.2006.10400584","article-title":"Integrated cognitive behavioral therapy versus twelve-step facilitation therapy for substance-dependent adults with depressive disorders.","volume":"38","author":"Brown","year":"2006","journal-title":"J Psychoactive Drugs"},{"key":"R37-7-20210128","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1037\/0022-006X.65.5.715","article-title":"Cognitive-behavioral treatment for depression in alcoholism.","volume":"5","author":"Brown","year":"1997","journal-title":"J Consult Clin Psychol"},{"issue":"3","key":"R38-7-20210128","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/oxfordjournals.aje.a112455","article-title":"Assessing depressive symptoms in five psychiatric populations: a validation study.","volume":"106","author":"Weissman","year":"1977","journal-title":"Am J Epidemiol"},{"issue":"6","key":"R39-7-20210128","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.phrs.2004.05.002","article-title":"Methadone-metabolism, pharmacokinetics and interactions.","volume":"50","author":"Ferrari","year":"2004","journal-title":"Pharmacol Res"},{"issue":"1","key":"R40-7-20210128","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/10550490050172236","article-title":"The effect of sertraline on methadone plasma levels in methadone-maintenance patients.","volume":"9","author":"Hamilton","year":"2000","journal-title":"Am J Addict"}],"container-title":["Journal of Clinical Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:27:04Z","timestamp":1786048024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004714-201110000-00007"}},"subtitle":["A Meta-Analysis"],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/jcp.0b013e31822c0adf","relation":{},"ISSN":["0271-0749"],"issn-type":[{"value":"0271-0749","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}